0001104659-22-094255.txt : 20220825 0001104659-22-094255.hdr.sgml : 20220825 20220825090036 ACCESSION NUMBER: 0001104659-22-094255 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20220825 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220825 DATE AS OF CHANGE: 20220825 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Marpai, Inc. CENTRAL INDEX KEY: 0001844392 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40904 FILM NUMBER: 221193421 BUSINESS ADDRESS: STREET 1: 5701 EAST HILLSBOROUGH AVENUE, SUITE 141 CITY: TAMPA STATE: FL ZIP: 33610 BUSINESS PHONE: 646-303-3483 MAIL ADDRESS: STREET 1: 5701 EAST HILLSBOROUGH AVENUE, SUITE 141 CITY: TAMPA STATE: FL ZIP: 33610 8-K 1 tm2224526d1_8k.htm FORM 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 8-K

CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 25, 2022

MARPAI, INC.

(Exact name of registrant as specified in its charter)

001-40904

(Commission File Number)

Delaware	86-1916231
(State or other jurisdiction of incorporation)	(I.R.S. Employer Identification No.)

5701 East Hillsborough Avenue, Suite 1417,
Tampa, Florida 33610

(Address of principal executive offices, with zip code)

(646) 303-3483

(Registrant's telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Ticker symbol(s)	Name of each exchange on which registered
Class A Common Stock, par value $0.0001 per share	MRAI	The Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company x

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 8.01 Other Events.

On August 25, 2022, Marpai, Inc. (“Marpai” or the “Company”) issued a press release announcing a new pharmacy benefit management (PBM) solution available to its clients nationwide called MarpaiRx. A copy of the press release is attached as Exhibit 99.1 hereto and is incorporated by reference herein.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit Number		Description
99.1		Press release of Marpai, Inc., dated August 25, 2022
104		Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

MARPAI, INC.

Date: August 25, 2022	By:	/s/ Edmundo Gonzalez
	Name:	Edmundo Gonzalez
	Title:	Chief Executive Officer

EX-99.1 2 tm2224526d1_ex99-1.htm EXHIBIT 99.1

Exhibit 99.1

Marpai Launches MarpaiRx Pharmacy Benefit Management Solution to Decrease Prescription Costs

New innovative PBM lowers drug costs for self-insured health plans and makes it easy for members to find affordable medications

NEW YORK, August 25, 2022 — Marpai, Inc., (“Marpai”) (Nasdaq: MRAI), an AI technology company transforming third-party administration (TPA) in the self-funded employer health plan market, announces a new pharmacy benefit management (PBM) solution available to current and potential clients nationwide called MarpaiRx. MarpaiRx is powered by a collaboration with MedOne Pharmacy Benefit Solutions (“MedOne”). MedOne is a trusted leader in the pharmacy benefit management market, delivering enhanced member experiences, improved clinical outcomes and net cost reduction through its aligned and performance-based model.

As pharmacy expenses can typically account for 20 percent or more of costs within a health plan and is the fastest growing cost area, it has a big influence on care and plan affordability. While many PBMs are scrutinized for driving up drug costs with manufacturer rebate retention and spread pricing, MarpaiRx provides a refreshing alternative. MarpaiRx is a patient-centric solution that guides health plan members towards the most cost-effective medication for their condition (rather than steering them toward a drug with a rebate), passes all discounts and eligible rebates on to clients and creates the formulary based on drug outcome performance.

“Our clients across the country are demanding simplicity and transparency as they provide prescription drug benefits to their employees. MarpaiRx provides a formulary that we believe is best suited to the needs of members in a given employer group. We are committed to better outcomes for members and transparency for the employers,” says Edmundo Gonzalez, Chief Executive Officer of Marpai.

MarpaiRx offers rigorous specialty medication management which is expected to deliver significant savings versus industry standards. It features proprietary pharmacy claims processing, custom formulary management, an integrated specialty and mail order pharmacy, results-oriented clinical programs and next-level customer service. MarpaiRx features innovative pharmacy benefit services including a real-time integration with nationally-recognized discount cards ensuring insurance costs are never higher than what is available to the general public. All prices are compared without any member effort with the lowest cost delivered to the member with application to deductibles and out-of-pocket maximums. MarpaiRx coordinates pharmacy and medical benefits to ensure that the right care is delivered and paid for in a way that reduces claims costs

“It can be challenging and overwhelming to understand your options when it comes to pharmacy benefits. Our unique approach to navigating prescription costs for members focuses on transparency and personalization. We believe that this will provide an immense impact to our members, ensuring they get the right prescription at the right price without any sacrifice to quality,” said Ronnie Brown, Chief Operating Officer at Marpai.

MarpaiRx is available to all Marpai clients nationwide and is soon to be part of the myMarpai App (available on Android and Apple devices) allowing health plan members to manage all healthcare needs in one place.

MarpaiRx is part of Marpai Cares, Marpai’s commitment to create the healthiest member population with the greatest cost efficiency within the health plan budget to maximize plan value. MarpaiRx joins a host of innovative AI-powered health plan services by Marpai designed to improve member health and reduce excessive health plan costs.

For more information, visit www.marpaihealth.com.

About Marpai, Inc.

Marpai, Inc. (Nasdaq: MRAI) is a technology company bringing AI-powered health plan services to employers that directly pay for employee health benefits. Primarily competing in the $22 billion TPA (Third Party Administrator) sector serving self-funded employer health plans representing over $1 trillion in annual claims, Marpai maximizes the value of the self-funded health plan by creating the healthiest member population with the greatest cost efficiency within the plan budget. Marpai uses AI and big data to proactively fill gaps in care for members, implement meaningful interventions that impact near-term outcomes and guide members to high-value provider and pharmacy solutions to reduce avoidable care, excessive utilization, inappropriate care and excessive costs. Operating nationwide, Marpai offers access to provider networks including Aetna and Cigna and all TPA services. For more information, visit www.marpaihealth.com, the content of which is not incorporated by reference into this press release.

About MedOne Pharmacy Benefit Solutions

MedOne helps organizations and their health plan members conveniently access the most appropriate prescription at the most affordable price through its aligned and performance-based pharmacy benefit solution. MedOne’s offering focuses on enhancing the member’s pharmacy benefit experience, improving clinical outcomes and reducing net cost for plan sponsors and their members. MedOne operates in all 50 states and its customer base includes organizations of all sizes and across a variety of industries. MedOne is honored to be included in the 2022 Inc. Magazine’s 5000 fastest growing private companies in America. For more information, visit www.medone-rx.com.

Forward-looking Statements

This press release contains forward-looking statements, as that term is defined in the Private Litigation Reform Act of 1995, that involve significant risks and uncertainties, including statements regarding anticipated fourth-quarter results. Forward-looking statements can be identified through the use of words such as “anticipates,” “expects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” “may,” “can,” “could”, “will”, “potential”, “should,” “goal” and variations of these words or similar expressions. For example, the Company is using forward looking statements when it discusses the advantages of MarpaiRx, that its unique approach to navigating prescription costs for members makes it easy for members to find affordable medications, that MarpaiRx will provide an impact to its members, ensuring they get the right prescription at the right price without any sacrifice to quality, that MarpaiRx is soon to be a part of the myMarpai App, the potential savings that may be realized using MarpaiRx and the Company’s commitment to create the healthiest member population with the greatest cost efficiency within the health plan budget to maximize plan value. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect Marpai’s current expectations and speak only as of the date of this release. Actual results may differ materially from Marpai’s current expectations depending upon a number of factors. These factors include, among others, adverse changes in general economic and market conditions, competitive factors including but not limited to pricing pressures and new product introductions, uncertainty of customer acceptance of new product offerings and market changes, risks associated with managing the growth of the business. Except as required by law, Marpai does not undertake any responsibility to revise or update any forward-looking statements whether as a result of new information, future events or otherwise.

More detailed information about Marpai and the risk factors that may affect the realization of forward-looking statements is set forth in Marpai’s filings with the Securities and Exchange Commission. Investors and security holders are urged to read these documents free of charge on the SEC's web site at http://www.sec.gov.

Media contact:

Jane Cavalier for Marpai

jcavalier@marpaihealth.com

203-858-3801

Investor Relations contact:

Simon Li

Marpai, Inc.

simonli@marpaihealth.com

813-822-3950

###

EX-101.SCH 3 mrai-20220825.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 mrai-20220825_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 mrai-20220825_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 6 tm2224526d1_ex99-1img001.jpg GRAPHIC begin 644 tm2224526d1_ex99-1img001.jpg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htm IDEA: XBRL DOCUMENT

Cover	Aug. 25, 2022
Cover [Abstract]
Document Type	8-K
Amendment Flag	false
Document Period End Date	Aug. 25, 2022
Entity File Number	001-40904
Entity Registrant Name	MARPAI, INC.
Entity Central Index Key	0001844392
Entity Tax Identification Number	86-1916231
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	5701 East Hillsborough Avenue, Suite 1417
Entity Address, City or Town	Tampa
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	33610
City Area Code	646
Local Phone Number	303-3483
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Title of 12(b) Security	Class A Common Stock, par value $0.0001 per share
Trading Symbol	MRAI
Security Exchange Name	NASDAQ
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false

XML 8 tm2224526d1_8k_htm.xml IDEA: XBRL DOCUMENT 0001844392 2022-08-25 2022-08-25 iso4217:USD shares iso4217:USD shares 0001844392 false 8-K 2022-08-25 MARPAI, INC. 001-40904 DE 86-1916231 5701 East Hillsborough Avenue, Suite 1417 Tampa FL 33610 646 303-3483 false false false false Class A Common Stock, par value $0.0001 per share MRAI NASDAQ true false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

[L@]_ <^92WD^&2_4N/_C!CVI / M(DWU2BI9;A(2;GE>!G_%JP._$+)KV[]%6TAM8&7_)8KCV8@K M!L& >AA;TRXH7N6K^(6P9SR.@@L,>@,,I&D.%*_L]S("GRP2F6/=H4,D\(+S MH#<,,**F/5"\KG]1PAB>@V.RK,P/U4ZW4N%"7;V=-JV!XA5]5,1"2/R#7F M]%:"I:T\N$HG3],3%["%XJ?1^ >#NMKOP6#71!L%C^MUT?BA^MUD?E--_#Q M>OT=V5SK$LBZ #MD.P&;3N#C9?M9&-@'R36A_B^K7\F21R7D6VN7[U":I@PZ M2%CE;3CI9'1US-2,$6V+"TY^K])OKR.PE2EB^X4?W<1U"C^'R-OP#8VIOG]2R9]E M7&VLEWX'!9/8$!4L;P\R+FA4B<:M?@^7J]G]LS-8_(H8;5\EES8A(.OC-V M9<0$X@K'^FICMS]"M,+B[SBZ2MQWAV'[Q\(#L^[1).5K$/(N+D%7[<_J^X&1 M174^7DD#I^WJ,N$,5K!] 'Y?2VG>!O;(7?]C,OD/4$L#!!0 ( Y(&56? MH!OPL0( .(, - >&PO9KEMW MDOSAR+DCO9ZW="C<\W[)&D/1ZY8^\XT7'ND,E8QYU5;)VUC.2M;<%(R6=[< M9(EB0M-BK3MUIUQ+#J;3;D-O:%LZ//EI0&@U_%">/3&[HEDFQMV)8RY20 MIV!>@N%@I+'$>2I\0Q=@:9\"O @:L!SC**&-!6,2,H3O_;C\&3!IK5>%E#/! M)0V&8MTPY[C5=UX9%@_&%Q 9Y=VI\0QKRTZ+Y2T].PP_/LG>V)+;.'36-/+T08I:Q[V_LL)BS6;_,C16/'DL\&D'+R!6TH>N77B<&GY85FS MX[V;IJFO<,[+?Y#SGZUSS36W3%Z2]J/_-U?Y+8R3\?1<'-&K SI;"5R$&_H5 M[E=YYD#VG9!.Z%$[BK+D^L4Y]>$=V_L+_"J^7U_RBG72[69P0\_R%UZ3N7S MJGNHR[CJ+'^&^VB1S;>PSR5TR7M>;D?5UOM!)%[P6<<'')XC=\,31S"?@,41 MP+ \& /,)WAA>?ZG_:S0_00,X[:(BO49X7Z!\8LAT^6)ZX3^Z?^$[S/$VS M#OH=AMEL,7JEF7P%X^&<0,/+ ]D>ENM\6[C$_+Z'& ]?6U"L)WBDXCM%\U M(/&Z@4>>Q[N-Y0$/K O8[$#^>!Z8J;A/FD)7,6[8"<:1/,<0F,7XC&894IT, M/O'^8* \^>Q\ETWLJ.?]74_P$4$L# M!!0 ( Y(&567BKL
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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 / / v2.2.0.24 / / DefRef Styles / ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } / Report Styles / ..pl a, .pl a:visited { color: black; text-decoration: none; } / table / ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } / Top labels / ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; / word-wrap: break-word; / } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } / Header rows... / ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } / Calendars... / ..report .rc { background-color: #f0f0f0; } / Even rows... / ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } / Odd rows... / ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } / styles for footnote marker / ..report .fn { white-space: nowrap; } / styles for numeric types / ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } / styles for text types / ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2.2 html 1 23 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://marpaihealth.com/role/Cover Cover Cover 1 false false All Reports Book All Reports tm2224526d1_8k.htm mrai-20220825.xsd mrai-20220825_lab.xml mrai-20220825_pre.xml tm2224526d1_ex99-1.htm http://xbrl.sec.gov/dei/2021q4 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "tm2224526d1_8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "tm2224526d1_8k.htm" ] }, "labelLink": { "local": [ "mrai-20220825_lab.xml" ] }, "presentationLink": { "local": [ "mrai-20220825_pre.xml" ] }, "schema": { "local": [ "mrai-20220825.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021q4": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 0, "nsprefix": "MRAI", "nsuri": "http://marpaihealth.com/20220825", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm2224526d1_8k.htm", "contextRef": "From2022-08-25to2022-08-25", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://marpaihealth.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm2224526d1_8k.htm", "contextRef": "From2022-08-25to2022-08-25", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r11", "r13", "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r19" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021q4", "presentation": [ "http://marpaihealth.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r10": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r11": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r12": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r13": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r14": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r15": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r16": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r17": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r18": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r19": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r9": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" } }, "version": "2.1" } ZIP 15 0001104659-22-094255-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-22-094255-xbrl.zip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end